Position in RCKT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,771,191
+$3,950,175 QoQ
Shares Held
3,567,372
+42.0% QoQ
Ownership
3.27%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Common Shares in RCKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MAVERICK CAPITAL LTD holds $642,068,880 across 12 Biotechnology names. RCKT ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
4,739,721 | $247,697,819 | |
| 2 | PCVX |
Vaxcyte, Inc.
|
1,377,738 | $80,060,355 | |
| 3 | WVE |
Wave Life Sciences Ltd.
|
10,161,399 | $73,670,142 | |
| 4 | CNTA |
Centessa Pharmaceuticals plc
|
1,854,488 | $73,660,263 | |
| 5 | NAMS |
NewAmsterdam Pharma Co N.V.
|
2,186,402 | $69,986,728 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,626,940 | $45,066,238 | |
| 7 | IVVD |
Invivyd, Inc.
|
18,970,913 | $24,662,186 | |
| 8 | RCKT |
Rocket Pharmaceuticals, Inc.
This page
|
3,567,372 | $12,771,191 |
All Filings in RCKT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,771,191 | 3,567,372 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,821,016 | 2,513,110 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $8,821,016 | 2,513,110 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $27,606,801 | 8,468,344 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,491,341 | 8,363,813 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $20,491,341 | 8,363,813 | Shares | Sole | 2025-08-14 | |
| 2025-04-07 | $28,789,838 | 5,547,175 | Shares | Sole | 2025-04-14 | |
| 2025-03-31 | $34,678,784 | 5,199,218 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $65,350,173 | 5,198,900 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $76,071,871 | 4,118,672 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $84,576,557 | 3,928,312 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $104,751,125 | 3,888,312 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $120,901,017 | 4,034,068 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $115,358,085 | 5,629,970 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $87,030,003 | 4,379,970 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $75,502,581 | 4,407,623 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $66,456,158 | 3,395,818 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $40,416,561 | 2,532,366 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $34,845,356 | 2,532,366 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $33,832,012 | 2,133,166 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $41,367,107 | 1,894,966 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $49,620,867 | 1,660,116 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,701,455 | 173,887 | Shares | Sole | 2021-08-18 | |
| No filing history on record for this holder in this stock. | ||||||